Related Experiment Videos
Current clinical perspectives on implantable devices for atrial defibrillation
Giuseppe Boriani1, Mauro Biffi, Cristian Martignani
1Institute of Cardiology, University of Bologna, Bologna, Italy. cardio1@almadns.unbo.it
Current Opinion in Cardiology
|January 16, 2002
Summary
Implantable atrial defibrillators show promise for select atrial fibrillation patients when used with other treatments. While not a standalone solution, these devices may benefit specific patient groups alongside medications, pacing, or ablation.
Area of Science:
- Cardiology
- Medical Devices
- Electrophysiology
Background:
- The efficacy of shock therapy devices for atrial fibrillation remains under discussion.
- Advancements in catheter-based atrial defibrillation have led to new implantable device options.
Purpose of the Study:
- To evaluate the role and potential benefits of implantable atrial defibrillators.
- To assess the utility of these devices in managing atrial fibrillation.
Main Methods:
- Review of technical improvements in catheter-based atrial defibrillation.
- Analysis of the availability of stand-alone and dual implantable atrial defibrillators.
Main Results:
- Preliminary findings suggest atrial defibrillators are not effective as a sole treatment for atrial fibrillation.
- Implantable devices may offer benefits when combined with pharmacotherapy, pacing, or ablation.
Conclusions:
- Atrial defibrillators are not recommended as a singular treatment for all atrial fibrillation patients.
- Appropriately selected patients may benefit from atrial defibrillators in conjunction with other therapeutic strategies.